Authors
Chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida.
Shayla Bergmann, MD, is a clinical professor in pediatric hematology at the Medical University of South Carolina.
Nathanael Hwang, research intern, Beth Israel Deaconess Medical Center
Advertisement
Advertisement
Trending on AJMC
1
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
2
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
3
5 Ongoing Clinical Trials in Myeloproliferative Neoplasms
4
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
5
